ヨーロッパのオピオイド市場は、2022年に45億5,386万米ドルと評価され、2030年までに52億3,772万米ドルに達すると予想されています。2022年から2030年までに1.8%のCAGRが記録されると推定されています。
心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を与えます。さらに、これらの症状に苦しむ多くの患者は慢性的な痛みを経験しています。上記の病気は、成人および高齢者集団に最もよく見られます。それにもかかわらず、これらの病気の症例は子供の間でも顕著に増加しています。慢性的な痛みは、スポーツ選手、アスリート、過去に怪我を負った人にもよく見られます。 NCBI（国立バイオテクノロジー情報センター）で発表された研究によると、世界中で成人の20%が痛みに苦しんでおり、毎年10%が新たに慢性疼痛と診断されています。痛みは性別、人種/民族、収入、年齢、地理に関係なく、すべての人々に影響を及ぼしますが、痛みは世界中に平等に分布しているわけではありません。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、怪我、手術、がんや関節炎などの健康状態によって引き起こされる痛みの治療に使用される強力な鎮痛薬です。オピオイド処方の増加は、代替疼痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的なケアを奨励するコスト構造、患者の満足度と効果的な疼痛管理を組み合わせた評価に起因すると考えられます。したがって、疼痛管理におけるオピオイドの利点により、慢性疾患患者の間で需要が高まっています。
ヨーロッパのオピオイド市場は、ドイツ、イギリス、フランス、イタリア、スペイン、その他のヨーロッパに分割されています。ヨーロッパはヨーロッパのオピオイド市場で重要な位置を占めており、予測期間中に市場は力強い成長を遂げると予想されています。この地域の市場成長は主に、慢性疼痛を引き起こす疾患（関節炎、腰痛、線維筋痛症など）の有病率の上昇と、オピオイド薬物中毒（ヘロインなど）の治療薬の入手可能性の急増に起因しています。例えば、メタドンはヨーロッパで最も処方されているオピオイド作動薬であり、患者の75%がオピオイド作動薬の維持療法に使用しています。ブプレノルフィンは、この地域で2番目に使用されているオピオイド作動薬です。ただし、クロアチア、キプロス、チェコ共和国、フィンランド、フランス、スウェーデンでは最も頻繁に使用されているオピオイド維持療法の1つです。コデインはキプロスとドイツで主に使用されている作動薬ですが、ジアセチルモルヒネはベルギー、デンマーク、ドイツ、オランダ、スペイン、イギリス、アイルランドで一般的に使用されているものです。
ヨーロッパのオピオイド市場は、製品に基づいて即時放出型短時間作用型オピオイドと徐放型長時間作用型オピオイドに分類されます。即時放出型短時間作用型オピオイドセグメントは、2022年に大きな市場シェアを保持しました。即時放出型短時間作用型オピオイドは、オキシコドン、ヒドロコドン、トラマドール、コデイン、プロポキシフェンなどにさらにサブセグメント化されています。徐放性長時間作用性オピオイドは、オキシコドン、フェンタニル、モルヒネ、メサドンなどにさらにサブセグメント化されます。
用途に関して、ヨーロッパのオピオイド市場は、疼痛管理、麻酔、下痢抑制、咳止め、依存症解消などに分類されます。疼痛管理セグメントは、2022年に最大の市場シェアを保持しました。
ヨーロッパのオピオイド市場は、国ごとにイギリス、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパに分割されています。2022年のヨーロッパのオピオイド市場シェアはイギリスが独占しました。
Endo International plc社、Mallinckrodt Plc社、Neuraxpharm Pharmaceuticals SL社、Hikma Pharmaceuticals Plc社、Rusan Pharma Ltd社、およびTeva Pharmaceutical Industries Ltd社は、ヨーロッパのオピオイド市場で事業を展開する大手企業です。
目次
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Europe Analysis
5.1 Europe Opioids Market Overview
5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030
5.3 Europe Opioids Market Forecast Analysis
6. Europe Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Europe Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Opioids Market - Country Analysis
10.1 Europe
10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product
10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application
10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product
10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application
10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product
10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application
10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application
10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product
10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application
10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Opioids Market Segmentation
Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
LIST OF FIGURES
Figure 1. Europe Opioids Market Segmentation, by Country
Figure 2. Europe Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
